NCT02274272 Effects of Genmont Probiotic on Improve the Level of Blood Glucose and Other Diabetic Associate Parameter in Type 2 Diabetes Patients Status COMPLETED Phase PHASE2
NCT02263677 Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI Status WITHDRAWN Phase PHASE4
NCT02262208 Exercise as a Tool for Studying the Mechanisms and Applicability of Glycemic Variability Status UNKNOWN Phase NA
NCT02248857 Promoting the Universal Medication Schedule Via Mobile and EHR Technologies Status COMPLETED Phase NA
NCT02246400 CardioMetabolic Program Meets eHealth: Redesign and Evaluation for Optimal Reach and Impact Status COMPLETED Phase NA
NCT02244164 Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments. Status TERMINATED Phase NA
NCT02236962 Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment Status UNKNOWN Phase NA
NCT02235194 Effects of an Amino Acid and Chromium-picolinate Containing Drink on Glucose Metabolism Status COMPLETED Phase NA
NCT02227875 Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2) Status COMPLETED Phase PHASE3